Abstract
As a new type of immune tolerance inducer, anti-CD45RB monoclonal antibodies (anti-CD45RBmAb) can prolong the graft survival time of animal organs or cell transplantation as well as induce stable immune tolerance. Both interleukin (IL)-2 and IL-10 have important roles in the induction and maintenance of immunological tolerance. However, whether these cytokines combined with anti-CD45RBmAb can promote immune tolerance is poorly understood. Therefore, we investigated the effect of IL-2 and IL-10 in vitro and in vivo on the tolerance induction by anti-CD45RBmAb. The changes of Treg and Th17 cells and Th1/Th2 cytokines in anti-CD45RBmAb induced prolongation of skin allograft survival in mice. The finding of a role for IL-2 is novel, of interest, IL-2 promoted anti-CD45RBmAb-induced CD4+ T cell differentiation into Treg and Th2 cells and suppressed Th17 and Th1 cells. IL-2 enhanced the induction of immune tolerance by anti-CD45RBmAb and significantly prolonged skin graft survival time in vivo. In contrast, this effect should be demonstrated experimentally by neutralizing IL-2 and inhibition of the effect of anti-CD45RBmAb, and neutralizing IL-10 showed no effect for anti-CD45RBmAb-induced tolerance. These data reveal that IL-2 significantly enhances anti-CD45RBmAb-induced immune tolerance via up-regulated T regulatory (Treg) cells and the balance of Th1/Th2 shifts. Conversely, IL-10 showed no effect on anti-CD45RBmAb-induced tolerance.
Similar content being viewed by others
References
Davies JD, O’Connor E, Hall D, Krahl T, Trotter J, Sarvetnick N. CD4+CD45RB low-density cells from untreated mice prevent acute allograft rejection. J Immunol. 1999;163:5353–7.
Luke PP, Deng JP, Lian D, O’Connell PJ, Garcia B, Jevnikar AM, Zhong R. Prolongation of allograft survival by administration of anti-CD45RBmAb monoclonal antibody is due to alteration of CD45RBhi: CD45RBlo T-Cell proportions. Am J Transplant. 2006;6:2023–34.
Lazarovits AI, Poppema S, Zhang Z, Khandaker M, Le Feuvre CE, Singhal SK, Garcia BM, Ogasa N, Jevnikar AM, White MH, Singh G, Stiller CR, Zhong RZ. Prevention and reversal of renal allograft rejection by antibody against CD45RB. Nature. 1996;380:717–20.
Lee KM, Yeh H, Zhao G, Wei L, O’Connor M, Stott RT, Soohoo J, Dunussi K, Fiorina P, Deng S, Markmann JF, Kim JI. B-cell depletion improves islet allograft survival with anti-CD45RB. Cell Transplant. 2014;23(1):51–8.
Basadonna GP, Auersvald L, Khuong CQ, Zheng XX, Kashio N, Zekzer D, Minozzo M, Qian H, Visser L, Diepstra A, Lazarovits AI, Poppema S, Strom TB, Rothstein DM. Antibody-mediated targeting of CD45 isoforms: a novel immunotherapeutic strategy. Proc Natl Acad Sci. 1998;95:3821–6.
Sho M, Harada H, Rothstein DM, Sayegh MH. CD45RB-targeting strategies for promoting long-term allograft survival and preventing chronic allograft vasculopathy. Transplantation. 2003;75:1142–6.
Zheng SG, Wang J, Wang P, Gray JD, Horwitz DA. IL-2 is essential for TGF-beta to convert naive CD4+CD25− Cells to CD25+Foxp3+ regulatory T Cells and for expansion of these cells. J Immunol. 2007;178:2018–27.
Laurence A, Tato CM, Davidson TS, Kanno Y, Chen Z, Yao Z, Blank RB, Meylan F, Siegel R, Hennighausen L, Shevach EM, O’shea JJ. Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity. 2007;26:371–81.
Piccioni M, Chen Z, Tsun A, Li B. Regulatory T-cell differentiation and their function in immune regulation. Adv Exp Med Biol. 2014;841:67–97.
Bellinghausen I, Brand U, Steinbrink K, Enk AH, Knop J, Saloga J. Inhibition of human allergic T-cell responses by IL-10–treated dendritic cells: differences from hydrocortisone-treated dendritic cells. J Allergy Clin Immunol. 2001;108:242–9.
Zhao G, Moore DJ, Lee KM, Kim JI, Duff PE, O’Connor MR, Hirohashi T, Lei J, Yang M, Markmann JF, Deng S. An unexpected counter-regulatory role of IL-10 in B-lymphocyte-mediated transplantation tolerance. Am J Transplant. 2010;10:796–801.
Fecteau S, Basadonna GP, Freitas A, Ariyan C, Sayegh MH, Rothstein DM. CTLA-4 up-regulation plays a role in tolerance mediated by CD45. Nat Immunol. 2001;2:58–63.
Ariyan C, Salvalaggio P, Fecteau S, Deng S, Rogozinski L, Mandelbrot D, Sharpe A, Sayegh MH, Basadonna GP, Rothstein DM. Cutting edge: transplantation tolerance through enhanced CTLA-4 expression. J Immunol. 2003;171:5673–7.
Jen KY, Campo M, He H, Makani SS, Velasco G, Rothstein DM, Perkins DL, Finn PW. CD45RB ligation inhibits allergic pulmonary inflammation by inducing CTLA4 transcription. J Immunol. 2007;179:4212–8.
Deng S, Moore DJ, Huang X, Mohiuddin M, Lee MK IV, Velidedeoglu E, Lian MM, Chiaccio M, Sonawane S, Orlin A, Wang J, Chen H, Caton A, Zhong R, Markmann JF. Antibody-induced transplantation tolerance that is dependent on thymus-derived regulatory T cells. J Immunol. 2006;176:2799–807.
Qi H, Liu JP, Deng CY, Zhou HX, Deng SP, Li FR. A role for anti-CD45RB monoclonal antibody treatment upon dendritic cells. Immunol Res. 2012;52:250–7.
Deng S, Moore DJ, Huang X, Lian MM, Mohiuddin M, Velededeoglu E, Lee MK IV, Sonawane S, Kim J, Wang J, Chen H, Corfe SA, Paige C, Shlomchik M, Caton A, Markmann JF. Cutting edge: transplant tolerance induced by anti-CD45RBmAb requires B lymphocytes. J Immunol. 2007;178:6028–32.
Xia X, Zhang X, Huang X, Ichim TE, Li M, Luke P, Min W. Anti-CD45RBmAb monoclonal antibody induces immunologic toleration by suppressing dendritic cells. Transpl Immunol. 2009;21:136–9.
Langier S, Sade K, Kivity S. Regulatory T cells: the suppressor arm of the immune system. Autoimmun Rev. 2010;10:112–5.
Littman DR, Rudensky AY. Th17 and regulatory T Cells in mediating and restraining inflammation. Cell. 2010;140:845–58.
Anne Arai N. The molecular basis of T helper 1 and T helper 2 cell differentiation. Trends Cell Biol. 2000;10:542–50.
Schulz EG, Mariani L, Radbruch A, Höfer T. Sequential polarization and imprinting of type 1 T helper lymphocytes by interferon-γ and interleukin-12. Immunity. 2009;30:673–83.
Bayer AL, Yu A, Malek TR. function of the IL-2R for thymic and peripheral CD4+CD25+Foxp3+ T regulatory cells. J Immunol. 2007;178:4062–71.
Liao W, Lin JX, Wang L, Li P, Leonard WJ. Modulation of cytokine receptors by IL-2 broadly regulates differentiation into helper T cell lineages. Nat Immunol. 2011;12:551–9.
Bayer AL, Yu A, Adeegbe D, Malek TR. Essential role for interleukin-2 for CD4+CD25+ T regulatory cell development during the neonatal period. J Exp Med. 2005;201:769–77.
Li B, Tian L, Diao Y, Li X, Zhao L, Wang X. Exogenous IL-10 induces corneal transplantation immune tolerance by a mechanism associated with the altered Th1/Th2 cytokine ratio and the increased expression of TGF-β. Mol Med Rep. 2014;9:2245–50.
Furukawa Y, Becker G, Stinn JL, Shimizu K, Libby P, Mitchell RN. Interleukin-10 (IL-10) augments Allograft arterial disease: paradoxical effects of IL-10 in vivo. Am J Pathol. 1999;155:1929–39.
Richters CD, Hoekstra MJ, du Pont JS, Kreis RW, Kamperdijk EW. Immunology of skin transplantation. Clin Dermatol. 2005;23:338–42.
Acknowledgments
This work was supported by the national 973 special plan of China (No. 2007CB516811), the National Natural Science Foundation of China (No. 30772042), The Natural Science Foundation of Guangdong (No. 6027540) and The Science and Technology Project of Shenzhen (No. 201001005).
Conflict of interest
No competing financial interests exist.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Guo, WJ., Qi, H., Deng, CY. et al. The roles of IL-2 and IL-10 enhance anti-CD45RBmAb immune inhibition in allograft skin. Immunol Res 61, 250–259 (2015). https://doi.org/10.1007/s12026-014-8618-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12026-014-8618-9